Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
March 22, 2024Cancer Research

Abstract 1375: Abundance of KLRB1+ (CD161) T cells in anti-PD1 non responders coupled with enhanced tumor cytotoxicity of anti-CD161 (IMT-009) with anti-PD1 makes it a rational target for combination with anti-PD-(L)1 immunotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

AKAdwitiya KarTNTim O. NieuwenhuisMDMeixue Duan

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kar et al. (2024) studied this question.

synapsesocial.com/papers/68e72e1db6db6435876a7327https://doi.org/10.1158/1538-7445.am2024-1375
View Full Paper
Ask AI
Bookmark
Share